March 20, 2025AstraZeneca AZN: Among the Best Diabetes Stocks to Buy According to Billionaires ~1 min.AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....
March 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster ~2 min.AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....
March 15, 2025AstraZeneca's Experimental Blood Pressure Drug Shows Promising Results, Outperforms Broader Market ~1 min.AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....
March 14, 2025AstraZeneca's Imfinzi success a step towards revolutionizing cancer treatment ~2 min.AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....
February 28, 2025AstraZeneca PLC AZN: A Global Pharmaceutical Giant with Promising Growth Potential ~2 min.AstraZeneca PLC (AZN) is a renowned multinational pharmaceutical company with a strong presence in the global market....
January 15, 2025AstraZeneca PLC Faces Class Action Lawsuit Deadline for Stockholders: Robbins LLP Issues Reminder ~2 min.Robbins LLP, a global investor rights law firm, is reminding stockholders of AstraZeneca PLC (AZN) about the upcoming lead plaintiff deadline in the class action lawsuit against the company....
November 24, 2024AstraZeneca PLC Receives Acquisition Offer from Pathstone Holdings LLC ~1 min.Pathstone Holdings LLC has announced its intention to acquire AstraZeneca PLC, a leading pharmaceutical company specializing in immunotherapy....
December 11, 2024Hilltop Holdings Inc. Acquires Shares of 9368 AstraZeneca PLC NASDAQ:AZN ~1 min.AstraZeneca PLC (NASDAQ: AZN) has recently witnessed a significant acquisition of shares by Hilltop Holdings Inc....
October 30, 2024AstraZeneca Faces Investigation in China: Some Information for Investors ~2 min.AstraZeneca PLC, a multinational pharmaceutical company, is facing an investigation in China regarding the actions of its president....
December 21, 2024AstraZeneca Faces Investigation by Chinese Regulator, Shares Decline ~1 min.AstraZeneca PLC (AZN) shares have experienced a significant drop after reports emerged of a probe by the People's Republic of China (PRC) regarding alleged fraud and corruption....
